U.S. Department of Agriculture (USDA) scientists have developed a novel, antibiotic-free method that uses hyper immune egg yolk antibodies to control intestinal poultry diseases. The antibiotic-free technology involves extracting antibodies from egg yolks from pathogen-free hens or female chickens that have been injected with a vaccine that contains inactivated pathogenic organisms.
Scientists at the Agricultural Research Service Henry A. Wallace
Beltsville Agricultural Research Center (BARC) and collaborators from different
universities and the Mexican company IASA (Investigacíon Aplicada, S.A.)
demonstrated the effectiveness of inducing passive immunity in young birds,
which have no immune protection right after hatching, against coccidiosis,
a devastating poultry disease. Birds affected by coccidiosis are unable to absorb feed or gain
weight. The disease costs the poultry industry more than $600 million in the
United States and about $3 billion worldwide each year. Treatments used to
reduce the spread of disease include good management practices and live
vaccinations. However, antibiotic-free alternatives are important to help fight
drug-resistant strains and for organic poultry farmers.
In the study, one-day-old chickens were given feed mixed with spray-dried
egg yolk powder prepared from hens hyper immunized with multiple species of the
parasite Eimeria, which causes coccidiosis.
The chickens were then exposed to live coccidian parasites. Chickens that had received
the hyper immune egg yolk antibodies gained more weight and shed significantly
fewer Eimeria in their feces. The
treated birds also had less gut lesions than chickens that did not receive the
treatment.
Coccidiosis is associated with other pathogens,
such as the one that causes necrotic enteritis—a prevalent gut disease of
poultry," said avian immunologist Hyun Lillehoj, who works in BARC’s
Animal Parasitic Diseases Laboratory. “By controlling one, you’re also reducing
the impact of the other.
Aporte: Sebastián Pizarro Cortés - Ninoska Cordero
No hay comentarios.:
Publicar un comentario